Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ranibizumab”

538 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 538 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05407636
What this trial is testing

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

Who this might be right for
AMDnAMDWet Age-related Macular Degeneration+3 more
AbbVie 735
Large-scale testing (Phase 3)UnknownNCT05480293
What this trial is testing

This Study Will Compare the Efficacy and Safety of SCT510A Administered by Intravitreal Injection (IVT) With Ranibizumab in Patients With wAMD

Who this might be right for
Wet Age-related Macular Degeneration
Sinocelltech Ltd. 446
Testing effectiveness (Phase 2)Study completedNCT00288561
What this trial is testing

Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration (ARMD)
Novartis
Post-approval studies (Phase 4)Ended earlyNCT01319188
What this trial is testing

Ranibizumab and the Risk of Arterial Thromboembolic Events

Who this might be right for
Age-related Macular DegenerationCoronary Artery DiseaseCerebrovascular Disorders
Ural State Medical University 380
Not applicableUnknownNCT00455871
What this trial is testing

Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD

Who this might be right for
Age-Related Macular Degeneration
Barnes Retina Institute 30
Not applicableStudy completedNCT01025063
What this trial is testing

Use of Spectral OCT in Combination Therapy

Who this might be right for
Choroidal Neovascularization
Barnes Retina Institute 15
Not applicableStudy completedNCT05408416
What this trial is testing

Comparison of Surgery Outcome Between Preoperative IVR and Intraoperative IVR in PPV for PDR

Who this might be right for
Proliferative Diabetic Retinopathy
Peking University People's Hospital 102
Large-scale testing (Phase 3)WithdrawnNCT00557791
What this trial is testing

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON)

Who this might be right for
Age Related Macular Degeneration
OPKO Health, Inc.
Large-scale testing (Phase 3)UnknownNCT00454389
What this trial is testing

Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
NeoVista 494
Large-scale testing (Phase 3)Study completedNCT00567697
What this trial is testing

Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO

Who this might be right for
Central Retinal Vein OcclusionMacular Edema
Aleris Helse 32
Testing effectiveness (Phase 2)Study completedNCT00831350
What this trial is testing

Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations

Who this might be right for
Retinal Vein OcclusionPosterior Vitreous Detachment
Barnes Retina Institute 32
Early research (Phase 1)Study completedNCT00378196
What this trial is testing

Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial

Who this might be right for
Telangiectasia
Johns Hopkins University 10
Testing effectiveness (Phase 2)Ended earlyNCT01122511
What this trial is testing

Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular Degeneration

Who this might be right for
Subfoveal Choroidal NeovascularizationAge-Related Maculopathy
Allergan 4
Not applicableStudy completedNCT03459144
What this trial is testing

Comparison of PDT, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen

Who this might be right for
Polypoidal Choroidal Vasculopathy
Sun Yat-sen University 60
Post-approval studies (Phase 4)UnknownNCT01669447
What this trial is testing

Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of Lucentis

Who this might be right for
Degeneration of Macula and Posterior Pole
Osias Francisco de Souza 20
Post-approval studies (Phase 4)Study completedNCT03148132
What this trial is testing

VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP

Who this might be right for
Retinopathy of Prematurity Both EyesRetinal DiseasePremature Birth+1 more
Universidad Autonoma de San Luis Potosí 16
Early research (Phase 1)WithdrawnNCT00538538
What this trial is testing

Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD)

Who this might be right for
Retinal HemorrhageMacular Degeneration
Corewell Health East
Large-scale testing (Phase 3)Ended earlyNCT03203447
What this trial is testing

Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Clearside Biomedical, Inc. 325
Large-scale testing (Phase 3)Study completedNCT00764738
What this trial is testing

Study Investigating OCT, Multifocal ERG, and Microperimetry in Monthly Versus PRN Ranibizumab in Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration
Retina Macula Institute 91
Testing effectiveness (Phase 2)Study completedNCT00841581
What this trial is testing

Lucentis to Treat Pigment Epithelial Detachment

Who this might be right for
Pigment Epithelial Detachment
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 32
Next Page